Platelet activating factor (PAF) antagonists: development of a highly potent PAF antagonist, TCV-309. 1991

M Takatani, and N Maezaki, and Y Imura, and Z Terashita, and K Nishikawa, and S Tsushima
Chemistry Res. Labs, Takeda Chemical Industries, LTD., Osaka, Japan.

UI MeSH Term Description Entries
D007546 Isoquinolines A group of compounds with the heterocyclic ring structure of benzo(c)pyridine. The ring structure is characteristic of the group of opium alkaloids such as papaverine. (From Stedman, 25th ed)
D009536 Niacinamide An important compound functioning as a component of the coenzyme NAD. Its primary significance is in the prevention and/or cure of blacktongue and PELLAGRA. Most animals cannot manufacture this compound in amounts sufficient to prevent nutritional deficiency and it therefore must be supplemented through dietary intake. Nicotinamide,Vitamin B 3,Vitamin PP,3-Pyridinecarboxamide,Enduramide,Nicobion,Nicotinsäureamid Jenapharm,Papulex,Vitamin B3,3 Pyridinecarboxamide,B 3, Vitamin,B3, Vitamin,Jenapharm, Nicotinsäureamid
D010972 Platelet Activating Factor A phospholipid derivative formed by PLATELETS; BASOPHILS; NEUTROPHILS; MONOCYTES; and MACROPHAGES. It is a potent platelet aggregating agent and inducer of systemic anaphylactic symptoms, including HYPOTENSION; THROMBOCYTOPENIA; NEUTROPENIA; and BRONCHOCONSTRICTION. AGEPC,Acetyl Glyceryl Ether Phosphorylcholine,PAF-Acether,Phosphorylcholine, Acetyl Glyceryl Ether,1-Alkyl-2-acetyl-sn-glycerophosphocholine,Platelet Aggregating Factor,Platelet Aggregation Enhancing Factor,Platelet-Activating Substance,Thrombocyte Aggregating Activity,1 Alkyl 2 acetyl sn glycerophosphocholine,Aggregating Factor, Platelet,Factor, Platelet Activating,PAF Acether,Platelet Activating Substance
D011726 Pyridinium Compounds Derivatives of PYRIDINE containing a cation C5H5NH or radical C5H6N. Compounds, Pyridinium
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001381 Azepines Seven membered heterocyclic rings containing a NITROGEN atom. Hexamethyleneimines
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014230 Triazoles Heterocyclic compounds containing a five-membered ring with two carbon atoms and three nitrogen atoms with the molecular formula C2H3N3. Triazole

Related Publications

M Takatani, and N Maezaki, and Y Imura, and Z Terashita, and K Nishikawa, and S Tsushima
January 1992, Journal of lipid mediators,
M Takatani, and N Maezaki, and Y Imura, and Z Terashita, and K Nishikawa, and S Tsushima
October 1995, Transplantation proceedings,
M Takatani, and N Maezaki, and Y Imura, and Z Terashita, and K Nishikawa, and S Tsushima
February 1995, Transplantation proceedings,
M Takatani, and N Maezaki, and Y Imura, and Z Terashita, and K Nishikawa, and S Tsushima
February 1991, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme,
M Takatani, and N Maezaki, and Y Imura, and Z Terashita, and K Nishikawa, and S Tsushima
February 1992, The Journal of pharmacology and experimental therapeutics,
M Takatani, and N Maezaki, and Y Imura, and Z Terashita, and K Nishikawa, and S Tsushima
December 1992, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society,
M Takatani, and N Maezaki, and Y Imura, and Z Terashita, and K Nishikawa, and S Tsushima
September 1997, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation,
M Takatani, and N Maezaki, and Y Imura, and Z Terashita, and K Nishikawa, and S Tsushima
February 1995, Transplantation proceedings,
M Takatani, and N Maezaki, and Y Imura, and Z Terashita, and K Nishikawa, and S Tsushima
August 1993, Cardiovascular research,
Copied contents to your clipboard!